This website collects cookies to deliver better user experience. Cookie Policy
Accept
Sign In
The Wall Street Publication
  • Home
  • Trending
  • U.S
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
    • Markets
    • Personal Finance
  • Tech
  • Lifestyle
    • Lifestyle
    • Style
    • Arts
  • Health
  • Sports
  • Entertainment
Reading: CDC Backs Pfizer-BioNTech Booster for Immunocompromised Children
Share
The Wall Street PublicationThe Wall Street Publication
Font ResizerAa
Search
  • Home
  • Trending
  • U.S
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
    • Markets
    • Personal Finance
  • Tech
  • Lifestyle
    • Lifestyle
    • Style
    • Arts
  • Health
  • Sports
  • Entertainment
Have an existing account? Sign In
Follow US
© 2024 The Wall Street Publication. All Rights Reserved.
The Wall Street Publication > Blog > Business > CDC Backs Pfizer-BioNTech Booster for Immunocompromised Children
Business

CDC Backs Pfizer-BioNTech Booster for Immunocompromised Children

Editorial Board Published January 4, 2022
Share
CDC Backs Pfizer-BioNTech Booster for Immunocompromised Children
SHARE

The Pfizer-BioNTech Covid-19 vaccine is the only one authorized for people under 18 years.

Photo: Maddie McGarvey for The Wall Street Journal

By

Felicia Schwartz

Jan. 4, 2022 11:36 am ET

The Centers for Disease Control and Prevention recommended that many children with weakened immune systems get a booster from Pfizer Inc. PFE -3.74% and BioNTech SE BNTX -3.35% four weeks after their second shot.

The agency issued the recommendation Tuesday for moderately and severely immunocompromised children 5 to 11 years.

It also said that people who received the vaccine from Pfizer and partner BioNTech should receive a booster dose five months after their second shot, shortening the timeline by a month.

The recommendations “ensure that the most vulnerable children can get an additional dose to optimize protection against Covid-19,” said CDC director Rochelle Walensky.

The decisions follow the Food and Drug Administration’s authorization of both measures on Monday.

The FDA also cleared boosters for 12- to 15-year-olds, but the CDC is waiting to issue a recommendation until its advisory panel meets Wednesday to discuss expanding the shots to adolescents.

Many states and vaccination sites follow the recommendations of the CDC before giving the shots.

To bolster people’s protection against the Omicron variant, health authorities have been urging people to get an extra dose, and a growing number of institutions and businesses are mandating boosters.

Early research indicates the additional doses are needed to protect against Omicron.

To help combat Omicron, the Biden administration is opening up more Covid testing sites and delivering 500 million Covid tests to Americans. WSJ’s Daniela Hernandez breaks down why testing is still a pain point in the U.S., two years into the pandemic. Photo Illustration: David Fang

Fully vaccinated children between 5 and 11 years who aren’t immunocompromised don’t currently need boosters, the FDA said. It said it is reviewing additional data related to younger children and Covid-19.

The Pfizer-BioNTech Covid-19 vaccine is the only one authorized for people under 18 years, while shots from Moderna Inc. and Johnson & Johnson are cleared for those 18 and over.

The CDC’s recent booster moves don’t affect people who got the Moderna or Johnson & Johnson vaccines.

Under the CDC’s recommendations, people who took the Moderna vaccine should get a booster six months after their second dose, while Johnson & Johnson vaccine recipients should receive any booster dose two months after their initial dose.

The CDC has previously backed mixing and matching primary vaccine doses and boosters. Immunocompromised people ages 12 years and older had also been cleared to receive booster doses after one month.

Write to Felicia Schwartz at [email protected]

Covid-19 Vaccines

Copyright ©2022 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

Appeared in the January 5, 2022, print edition as ‘CDC Backs Booster For At-Risk Children.’

Contents
The Pfizer-BioNTech Covid-19 vaccine is the only one authorized for people under 18 years.Felicia SchwartzCovid-19 Vaccines
TAGGED:Business NewsPAIDWall Street Publication
Share This Article
Twitter Email Copy Link Print
Previous Article Investors, Here’s How to Brace for the Year of Central Bank Divergence Investors, Here’s How to Brace for the Year of Central Bank Divergence
Next Article GOP lawmakers urge Supreme Court to strike down Biden’s workplace vaccine-or-test order GOP lawmakers urge Supreme Court to strike down Biden’s workplace vaccine-or-test order

Editor's Pick

Emman Atienza Reason for Demise: Social Media Star Passes Away at 19

Emman Atienza Reason for Demise: Social Media Star Passes Away at 19

Studying Time: 2 minutes Beloved influencer Emman Atienza has been discovered lifeless in Los Angeles. She was simply 19 years…

By Editorial Board 2 Min Read
The 2025 Denim Playbook: The Finest Denims and Manufacturers for Each Type | Fashion
The 2025 Denim Playbook: The Finest Denims and Manufacturers for Each Type | Fashion

We independently consider all advisable services. Any services or products put ahead…

6 Min Read
10 Upcoming Sneaker Drops You Can’t Miss This October | Fashion
10 Upcoming Sneaker Drops You Can’t Miss This October | Fashion

We independently consider all beneficial services and products. Any services or products…

7 Min Read

Oponion

LGBTQ+ folks relive outdated traumas as they age on their very own

LGBTQ+ folks relive outdated traumas as they age on their very own

Invoice Corridor, 71, has been preventing for his life for…

December 29, 2024

The 2025 Hyundai Tucson Restricted AWD Hybrid SUV

What's a Tucson? The Tucson is…

January 26, 2025

Lori Loughlin Requested Husband’s Favourite Strippers for Recommendation

Studying Time: 4 minutes Lori Loughlin…

October 27, 2025

Warren Buffett touts US inventory holdings, Japan investments

Payne Capital Administration President Ryan Payne…

February 25, 2025

Right here’s what voters ought to do in the event that they get a proof-of-citizenship request in Arizona’s Maricopa County

Two letters went out. One was…

July 12, 2025

You Might Also Like

FundRelis Restora Brings Accountability to the Wild West of Online Scams
BusinessTrending

FundRelis Restora Brings Accountability to the Wild West of Online Scams

Zurich, Switzerland — In a financial era defined by digital innovation and unregulated trading, a quiet revolution is taking shape inside…

5 Min Read
Russia for Business: Experts Who Help Drive Decisions
BusinessTrending

Russia for Business: Experts Who Help Drive Decisions

Amid sanctions and the restructuring of global supply chains, understanding the logic behind Russia’s actions has become a practical necessity…

4 Min Read
The Quiet Shift in America’s Workforce: Why Side Hustles Are Becoming Essential for Women Over 40
BusinessTrending

The Quiet Shift in America’s Workforce: Why Side Hustles Are Becoming Essential for Women Over 40

Across the nation, a quiet but powerful workforce shift is underway. Increasingly, women over 40 are seeking side hustles to…

4 Min Read
Thales Reinforces its Management in eSIM and IoT Connectivity with a ‘Ready to Use’ Licensed Resolution
Business

Thales Reinforces its Management in eSIM and IoT Connectivity with a ‘Ready to Use’ Licensed Resolution

At a time when billions of linked objects are reshaping industries, Thales has achieved a vital safety certification for its…

4 Min Read
The Wall Street Publication

About Us

The Wall Street Publication, a distinguished part of the Enspirers News Group, stands as a beacon of excellence in journalism. Committed to delivering unfiltered global news, we pride ourselves on our trusted coverage of Politics, Business, Technology, and more.

Company

  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • WP Creative Group
  • Accessibility Statement

Contact

  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability

Term of Use

  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices

© 2024 The Wall Street Publication. All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?